Menu
← Oncology Approval Tracker
FDA DECISION ·
Pomalidomide (Pomalyst first generics)
pomalidomide · Breckenridge Pharmaceutical and Eugia Pharma Specialties
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Two first generic Pomalyst approvals for the same capsule strengths, covering selected adults with multiple myeloma with dexamethasone and adults with AIDS-related Kaposi sarcoma after antiretroviral failure or Kaposi sarcoma without HIV.
LAMPGEN ANALYSIS
Why it matters
Added generic applications for an oral agent used in hematologic and solid tumor care.
What research teams should watch
Check actual availability independently of approval and maintain required risk-management procedures.
PRIMARY RECORDS